Bispecific antibodies and CAR T cells targeting a TP53 mutation–associated neoantigen show discordant affinity requirements
Sarah R. DiNapoli(Howard Hughes Medical Institute), Bert Vogelstein(Howard Hughes Medical Institute), Evangeline Watson(Howard Hughes Medical Institute), Marco Dal Molin(Johns Hopkins University), Jacqueline Douglass(Howard Hughes Medical Institute), Alexander H. Pearlman(Johns Hopkins University), Joshua D. Cohen(Howard Hughes Medical Institute), Maria Popoli(Johns Hopkins University), Maximilian F. Konig(Johns Hopkins Medicine), Katharine M. Wright(Johns Hopkins University), Suman Paul(Johns Hopkins University), Nikita Marcou(Howard Hughes Medical Institute), Kathleen L. Gabrielson(Johns Hopkins University), Kenneth W. Kinzler(Johns Hopkins University), Brian J. Mog(Howard Hughes Medical Institute), Sandra B. Gabelli(Johns Hopkins University), Tushar D. Nichakawade(Howard Hughes Medical Institute), Nicolas Wyhs(Johns Hopkins University), Emily Han-Chung Hsiue(Howard Hughes Medical Institute), Shibin ZHOU(Johns Hopkins University), Michael S. Hwang(Howard Hughes Medical Institute), Jin Liu(Howard Hughes Medical Institute), Tolulope O. Awosika(Howard Hughes Medical Institute), Nickolas Papadopoulos(Johns Hopkins University), Qiang Liu(Howard Hughes Medical Institute), Jiaxin Ge(Howard Hughes Medical Institute), Stephanie Glavaris(Sidney Kimmel Comprehensive Cancer Center), Drew M. Pardoll(Johns Hopkins University), P. Aitana Azurmendi(Howard Hughes Medical Institute)
Cited by 0
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
|Science|2006|3.2k